To the best of our knowledge, our study is the first-of-its-kind to shed a light on the mechanism of miR-135a-5p targeting TXNIP to restrict NLRP3-inflammasomme activation in CFs. The gene discussed is NLRP3; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.